Identification and Preclinical Pharmacology of BMS-986104: A Differentiated S1P1 Receptor Modulator in Clinical Trials

doi 10.1021/acsmedchemlett.5b00448.s001
Full Text
Abstract

Available in full text

Date

Unknown

Authors

Unknown

Publisher

American Chemical Society (ACS)

Related search

Identification and Preclinical Pharmacology of Theγ-Secretase Modulator BMS-869780

International Journal of Alzheimer's Disease
AgingCognitive NeuroscienceMolecular NeuroscienceNeurologyBehavioral NeuroscienceCellular
2014English

Discovery and Preclinical Evaluation of BMS-955829 a Potent Positive Allosteric Modulator of mGluR5

English

Synthetic Antidiarrheal Drugs Synthesis Preclinical and Clinical Pharmacology

Gut
Gastroenterology
1976English

Immunotherapeutic Strategies in Breast Cancer: Preclinical and Clinical Trials

2007English

GABAA Receptor Genetics and Clinical Pharmacology

Current Anesthesiology Reports
AnesthesiologyPain Medicine
2014English

Molecular Pathways: Preclinical Models and Clinical Trials With Metformin in Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

Voxelotor (GBT440), a First-In-Class Hemoglobin Oxygen-Affinity Modulator, Has Promising and Reassuring Preclinical and Clinical Data

American Journal of Hematology
Hematology
2018English

Behavioural Pharmacology of the Α5-Gaba a Receptor Antagonist S44819: Enhancement and Remediation of Cognitive Performance in Preclinical Models

Neuropharmacology
Molecular NeuroscienceCellularPharmacology
2017English

Implementation of the New Eu Clinical Trials Regulation in Slovakia: Tasks and Challenges for the Discipline of Clinical Pharmacology

Clinical Therapeutics
Pharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy